文献速递皮肤肿瘤

无色素性肢端黑色素瘤与色素性肢端黑色素瘤的空间转录组差异

Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants.
PubMed 文献 · Br J Dermatol · 2024-01-01

本研究采用空间转录组分析,比较9例无色素性肢端黑色素瘤(AAM,29个感兴趣区域)与11例色素性肢端黑色素瘤(PAM,46个感兴趣区域)的转录组差异。发现AAM的S100b+肿瘤细胞区域翻译和 nonsense-mediated decay 通路富集,而抗原加工提呈、干扰素信号和黑色素生物合成通路下调;肿瘤相关免疫细胞区域CD8 T细胞和M1巨噬细胞减少,单核细胞和内皮细胞增多。

要点

  • AAM肿瘤细胞区域翻译相关通路活跃,抗原提呈和干扰素信号下调。
  • AAM免疫微环境中CD8 T细胞和M1巨噬细胞显著减少。
  • AAM中单核细胞和内皮细胞数量增加,黑色素合成通路下调。

核心结论

  • AAM与PAM在肿瘤细胞转录通路和免疫细胞组成上存在显著差异,可能解释两者临床病程不同。

研究设计与样本

  • 研究纳入9例AAM(29个ROI)和11例PAM(46个ROI),使用S100b和CD3形态标记进行空间转录组分析。

主要发现

  • 在S100b+肿瘤细胞区域,AAM对比PAM检测到11个上调差异表达基因(包括伴侣/泛素相关基因)和82个下调差异表达基因(包括人类白细胞抗原)。
  • 通路分析显示AAM的S100b+ ROI中翻译和nonsense-mediated decay通路显著富集,抗原加工提呈、干扰素信号和黑色素生物合成通路显著降低。
  • 肿瘤相关免疫细胞区域中,AAM对比PAM的CD8 T细胞数量显著减少(P=0.04),M1巨噬细胞显著减少(P=0.01)。
  • AAM对比PAM的单核细胞显著增加(P=0.04),内皮细胞显著增加(P=0.04)。

临床怎么用

  • 空间转录组特征提示AAM免疫微环境抑制,或可探索增强抗原提呈和干扰素信号的策略。

局限性

  • 样本量较小(AAM 9例,PAM 11例),结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amelanotic acral melanoma (AAM) is a rare type of acral melanoma that has a poor prognosis. OBJECTIVES: To investigate the transcriptomic differences between AAM and pigmented acral melanoma (PAM). METHODS: Differences in the spatially resolved transcriptomic profiles of 9 patients with AAM with 29 regions of interest (ROIs) and 11 patients with PAM with 46 ROIs were investigated using S100b and CD3 morphology markers. RESULTS: In S100b+ tumour cell areas, we detected 11 upregulated differentially expressed genes (DEGs; including chaperone/ubiquitin--associated DEGs) and 82 downregulated DEGs (including human leucocyte antigen) in AAMs vs. PAMs. Protein-protein interaction network and pathway analyses revealed significant enrichment of dysregulated translational and nonsense-mediated decay pathways but significant decreases in antigen processing and presentation, interferon signalling and melanin biosynthesis pathways in S100b+ ROIs of AAMs compared with PAMs. In tumour-associated immune cell areas, the numbers of CD8 T cells (P = 0.04) and M1 macrophages (P = 0.01) were significantly decreased, whereas those of monocytes (P = 0.04) and endothelial cells (P = 0.04) were increased in AAMs compared with PAMs. CONCLUSIONS: These findings could widen our understanding of the biological differences between AAMs and PAMs, which might result in a different clinical course. Melanoma is one of the most serious types of skin cancer. As melanoma starts in cells that produce melanin (the substance that produces hair, eye and skin colouration), melanoma tumours are usually brown or black. ‘Amelanotic melanoma’ is a subtype of melanoma that has little or no melanin pigmentation. Less than 2% of melanomas are amelanotic melanomas. ‘Acral melanoma’ is a type of melanoma that occurs on the hands and feet. In acral melanoma, the lack of pigmentation has been associated with worse outcomes for patients. Why amelanotic acral melanoma (or ‘AAM’) has a worse prognosis than pigmented acral melanoma (or ‘PAM’) is unclear. Using a type of technology called ‘spatial transcriptomic analysis’, we analysed a type of nucleic acid called RNA in 9 people with AAM and 11 with PAM. Seventy-five ‘regions of interest’ were selected. These regions of interest are known to be associated with tumour cells or immune cells around tumours. We found that pathways involved in making proteins (translation) and in a process that removes faulty proteins called ‘messenger RNA’ were more active in AAM. However, pathways involved in processing and presenting antigens (substances that can trigger an immune response), the signalling of other proteins called ‘interferons’ and melanin production were less active in AAM. The number of specific types of white blood cells that recognize and attack tumours were decreased, whereas other cell types such as cells that line blood vessels were increased in AAM. Our findings could increase our understanding of the differences between AAMs and PAMs. This may lead to an improvement in prognosis.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Choi ME, Choi EJ, Lee JH, et al. Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants. Br J Dermatol. 2024. PMID: 38815138. doi:10.1093/bjd/ljae224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。